Institutional investors hold a majority ownership of PCRX through the 120.77% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended September 2015, these large investors purchased a net $2.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
COLUMBUS CIRCLE INVESTORS Bought 738.7 Thousand shares of Pacira Pharmaceuticals In...
FRONTIER CAPITAL MANAGEMENT CO. ... Bought 189.7 Thousand shares of Pacira Pharmaceuticals In...